Behavioral Health Business January 8, 2024
Medications like methadone and buprenorphine have become the gold standard for treating opioid use disorder (OUD). Still, many people with OUD still receive abstinence-based treatment or no treatment at all for the chronic disorder.
People with OUD who receive abstinence-only treatment are more likely to die than people who receive no treatment at all, according to a new study published in the Journal of Drug and Alcohol Dependence.
The study, led by Yale researchers, analyzed data from 965 people who died from an opioid-involved overdose in 2017. While previous research has compared abstinence-only treatment with medication-based treatments, this study is the first to compare the two paths with no treatment at all.
The results determined that medications for OUD significantly...
Today's Sponsors
Today's Sponsor